In Vivo Preclinical Assessment of β-Amyloid-Affine [ 11 C]C-PIB Accumulation in Aluminium-Induced Alzheimer's Disease-Resembling Hypercholesterinaemic Rat Model
Aluminum (Al) excess and hypercholesterinaemia are established risks of Alzheimer's disease (AD). The aim of this study was to establish an AD-resembling hypercholesterinaemic animal model-with the involvement of 8 week and 48 week-old Fischer-344 rats-by Al administration for the safe and rapi...
Saved in:
Published in | International journal of molecular sciences Vol. 23; no. 22; p. 13950 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
12.11.2022
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Aluminum (Al) excess and hypercholesterinaemia are established risks of Alzheimer's disease (AD). The aim of this study was to establish an AD-resembling hypercholesterinaemic animal model-with the involvement of 8 week and 48 week-old Fischer-344 rats-by Al administration for the safe and rapid verification of β-amyloid-targeted positron emission tomography (PET) radiopharmaceuticals. Measurement of lipid parameters and β-amyloid-affine [
C]C-Pittsburgh Compound B ([
C]C-PIB) PET examinations were performed. Compared with the control, the significantly elevated cholesterol and LDL levels of the rats receiving the cholesterol-rich diet support the development of hypercholesterinaemia
≤ 0.01
. In the older cohort, a notably increased age-related radiopharmaceutical accumulation was registered compared to in the young (
≤ 0.05;
≤ 0.01
. A monotherapy-induced slight elevation of mean standardised uptake values (SUV
) was statistically not significant; however, adult rats administered a combined diet expressed remarkable SUV
increment compared to the adult control (SUV
: from 0.78 ± 0.16 to 1.99 ± 0.28). One and two months after restoration to normal diet, the cerebral [
C]C-PIB accumulation of AD-mimicking animals decreased by half and a third, respectively, to the baseline value. The proposed in vivo Al-induced AD-resembling animal system seems to be adequate for the understanding of AD neuropathology and future drug testing and radiopharmaceutical development. |
---|---|
Bibliography: | These authors contributed equally to this work. |
ISSN: | 1422-0067 1661-6596 1422-0067 |
DOI: | 10.3390/ijms232213950 |